ANTX Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 20.79%
Insider Buying (Last 12 Months): $1,762,684.56
Insider Selling (Last 12 Months): $9,704,350.16

(ANTX) Insider Trading History Chart

This chart shows the insider buying and selling history at (ANTX) by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

(ANTX) Share Price & Price History

Current Price: $1.43
Price Change: Price Decrease of -0.05 (-3.38%)
As of 12/13/2024 01:00 AM ET

This chart shows the closing price history over time for ANTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

(ANTX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/9/2024Robin Shane ReadnourDirectorBuy30,772$1.43$44,003.96647,573View SEC Filing Icon  
12/6/2024Robin Shane ReadnourDirectorBuy19,228$1.45$27,880.60629,090View SEC Filing Icon  
11/27/2024Joseph S ZakrzewskiDirectorBuy2,000$1.40$2,800.00125,199View SEC Filing Icon  
11/20/2024Robin Shane ReadnourDirectorBuy50,000$1.16$58,000.00585,073View SEC Filing Icon  
11/18/2024Eric EasomCEOBuy50,000$1.00$50,000.001,065,766View SEC Filing Icon  
11/18/2024Joseph S ZakrzewskiDirectorBuy20,000$1.00$20,000.00118,199View SEC Filing Icon  
8/14/2024Braden Michael LeonardMajor ShareholderBuy1,500,000$1.04$1,560,000.005,749,432View SEC Filing Icon  
8/9/2024Ra Capital Management, L.P.Major ShareholderSell3,525,094$1.08$3,807,101.52300,853View SEC Filing Icon  
1/18/2024Joseph S ZakrzewskiDirectorSell100,000$19.11$1,911,000.00405,880View SEC Filing Icon  
1/16/2024Global Health Technol AdjuvantMajor ShareholderSell84,093$19.65$1,652,427.451,995,958View SEC Filing Icon  
1/16/2024Kabeer AzizDirectorSell100,000$19.65$1,965,000.00377,542View SEC Filing Icon  
1/12/2024Robin Shane ReadnourDirectorSell1,425$21.91$31,221.75414,788View SEC Filing Icon  
1/10/2024Robin Shane ReadnourDirectorSell3,669$21.93$80,461.17415,494View SEC Filing Icon  
1/9/2024Kevin Michael KrauseInsiderSell7,417$20.14$149,378.381,914View SEC Filing Icon  
1/2/2024Eric EasomCEOSell2,777$20.09$55,789.932,130View SEC Filing Icon  
1/2/2024Kevin Michael KrauseInsiderSell2,583$20.12$51,969.961,914View SEC Filing Icon  
11/14/2023Global Health Technol AdjuvantMajor ShareholderSell1,522$16.15$24,580.302,080,051View SEC Filing Icon  
11/14/2023Kabeer AzizDirectorSell1,810$16.15$29,231.50393,449View SEC Filing Icon  
10/2/2023Global Health Technol AdjuvantMajor ShareholderSell4,770$16.07$76,653.902,081,573View SEC Filing Icon  
10/2/2023Kabeer AzizDirectorSell5,672$16.07$91,149.04393,737View SEC Filing Icon  
9/29/2023Global Health Technol AdjuvantMajor ShareholderSell83,337$16.28$1,356,726.362,086,343View SEC Filing Icon  
9/29/2023Kabeer AzizDirectorSell99,101$16.28$1,613,364.28394,639View SEC Filing Icon  
9/27/2023Global Health Technol AdjuvantMajor ShareholderSell707$16.07$11,361.492,176,840View SEC Filing Icon  
9/27/2023Kabeer AzizDirectorSell841$16.07$13,514.87411,759View SEC Filing Icon  
9/13/2023Global Health Technol AdjuvantMajor ShareholderSell336$16.00$5,376.002,177,547View SEC Filing Icon  
9/13/2023Kabeer AzizDirectorSell400$16.00$6,400.00411,893View SEC Filing Icon  
9/6/2023Global Health Technol AdjuvantMajor ShareholderSell3,164$16.02$50,687.282,180,724View SEC Filing Icon  
9/6/2023Kabeer AzizDirectorSell3,762$16.02$60,267.24412,494View SEC Filing Icon  
8/23/2023Global Health Technol AdjuvantMajor ShareholderSell336$16.00$5,376.002,183,888View SEC Filing Icon  
8/23/2023Kabeer AzizDirectorSell400$16.00$6,400.00413,092View SEC Filing Icon  
8/18/2023Ra Capital Management, L.P.Major ShareholderBuy1,777,778$9.00$16,000,002.005,135,683View SEC Filing Icon  
5/15/2023Eric EasomCEOBuy10,000$5.38$53,800.001,015,766View SEC Filing Icon  
11/14/2022Eric EasomCEOSell23$15.04$345.924,907View SEC Filing Icon  
11/9/2022Eric EasomCEOSell10,111$15.61$157,832.714,907View SEC Filing Icon  
11/7/2022Eric EasomCEOSell12,203$16.04$195,736.124,907View SEC Filing Icon  
11/4/2022Eric EasomCEOSell8,828$15.80$139,482.4017,110View SEC Filing Icon  
11/2/2022Eric EasomCEOSell1,544$15.07$23,268.084,907View SEC Filing Icon  
10/31/2022Eric EasomCEOSell2,688$15.39$41,368.326,451View SEC Filing Icon  
10/28/2022Eric EasomCEOSell1,683$15.09$25,396.474,907View SEC Filing Icon  
10/26/2022Eric EasomCEOSell1,678$15.10$25,337.804,907View SEC Filing Icon  
10/24/2022Eric EasomCEOSell2,866$16.17$46,343.2211,391View SEC Filing Icon  
10/20/2022Eric EasomCEOSell7,293$16.68$121,647.2418,858View SEC Filing Icon  
8/3/2022Ra Capital Management, L.P.Major ShareholderBuy1,809$7.48$13,531.323,773,417View SEC Filing Icon  
7/26/2022Ra Capital Management, L.P.Major ShareholderBuy14,938$7.71$115,171.983,763,327View SEC Filing Icon  
6/21/2022Ra Capital Management, L.P.Major ShareholderBuy302$7.99$2,412.983,748,389View SEC Filing Icon  
6/13/2022Ra Capital Management, L.P.Major ShareholderBuy20,000$7.90$158,000.003,686,663View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for (ANTX) (NYSE:ANTX)

90.47% of (ANTX) stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

(ANTX) logo
Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care guidance; and Medicare administrative services. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2017, it served 40.2 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Read More on (ANTX)

Today's Range

Now: $1.43
Low: $1.43
High: $1.48

50 Day Range

MA: N/A

52 Week Range

Now: $1.43
Low: $47.02
High: $64.78

Volume

156,371 shs

Average Volume

1,031,814 shs

Market Capitalization

$42.73 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.11

Who are the company insiders with the largest holdings of (ANTX)?

(ANTX)'s top insider shareholders include:
  1. Braden Michael Leonard (Major Shareholder)
  2. Ra Capital Management, LP (Major Shareholder)
  3. Global Health Technol Adjuvant (Major Shareholder)
  4. Eric Easom (CEO)
  5. Robin Shane Readnour (Director)
  6. Kabeer Aziz (Director)
  7. Joseph S Zakrzewski (Director)
  8. Kevin Michael Krause (Insider)
Learn More about top insider investors at (ANTX).